Protective Effects of Selenium in Patients with Beta-Thalassemia Major

Protective Effects of Selenium in Patients with Beta-Thalassemia Major


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: آژند ابوطالبی , ابوالقاسم جویبان , سید هادی چاوشی , علی اکبر موثق پور اکبری , الناز شاسب , پروین سربخش , صبا غفاری

کلمات کلیدی: -Beta-thalassemia major -Selenium -Iron overload -Liver -Creatinine -Hair

نشریه: 27159 , 1 , 26 , 2020

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله صبا غفاری
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات هماتولوژی و انکولوژی
کد مقاله 71734
عنوان فارسی مقاله Protective Effects of Selenium in Patients with Beta-Thalassemia Major
عنوان لاتین مقاله Protective Effects of Selenium in Patients with Beta-Thalassemia Major
ناشر 7
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Background: Beta-thalassemia major patients require repeated blood transfusion which is associated with iron overload in different organs such as heart, liver, kidney and their related complications. In this study the effects of selenium in iron overload related complications of patients with beta-thalassemia major were assessed. Methods: In this clinical trial, 34 beta-thalassemia major patients over 12 years old were enrolled. Patients with severe renal failure, history of selenium consumption over the last three months, change of blood transfusion pattern, and any change of chelating agent were excluded from the study. For all patients, tablet of selenium 200 µg/day was administered for a month. Blood samples were taken at baseline and after one-month to assess the level of ferritin, total iron-binding capacity (TIBC), aspartate aminotransferase (AST), alanine aminotransferase (ALT), serum creatinine (Scr), selenium. Hair loss was assessed by questionnaire before and after intervention. Results: From 34 patients, 27 (79.4%) had deficient level of selenium at baseline. The selenium level was increased after intervention (p=0.005). The level of serum ALT and Scr decreased remarkably after one-month selenium consumption (p=0.007 for both). In addition, the AST level decreased remarkably after intervention (p=0.053). Severe hair loss profile has improved significantly after supplementation (p=0.004). Conclusion: One-month selenium consumption improved liver and kidney function related markers remarkably. Moreover, selenium improved hair profile and severe hair loss in thalassemia patients. Further studies are needed on the effect of selenium administration on liver and kidney function

نویسندگان
hide/show

نویسنده نفر چندم مقاله
آژند ابوطالبیاول
ابوالقاسم جویباندوم
سید هادی چاوشیسوم
علی اکبر موثق پور اکبریچهارم
الناز شاسبپنجم
پروین سربخشششم
صبا غفاریهفتم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
ps-26-25.pdf1399/01/281518330دانلود